133 related articles for article (PubMed ID: 21547136)
1. p53 gene therapy in combination with transcatheter arterial chemoembolization for HCC: one-year follow-up.
Guan YS; Liu Y; He Q; Li X; Yang L; Hu Y; La Z
World J Gastroenterol; 2011 Apr; 17(16):2143-9. PubMed ID: 21547136
[TBL] [Abstract][Full Text] [Related]
2. Trans-arterial p53-gene-embolization with gelatin sponge microparticles for hepatocellular carcinoma with BCLC stage B: single-center experience.
Liu Y; Zhang Y; Bautista D; Tang S; Zhou J; Li C; Zhao G
Cell Biochem Biophys; 2015 Jan; 71(1):99-104. PubMed ID: 25323562
[TBL] [Abstract][Full Text] [Related]
3. 131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma.
He Q; Lu WS; Liu Y; Guan YS; Kuang AR
World J Gastroenterol; 2013 Dec; 19(47):9104-10. PubMed ID: 24379637
[TBL] [Abstract][Full Text] [Related]
4. Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a pilot phase II trial.
Tian G; Liu J; Zhou JS; Chen W
Anticancer Drugs; 2009 Jun; 20(5):389-95. PubMed ID: 19287305
[TBL] [Abstract][Full Text] [Related]
5. The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization.
Kim PH; Gwon DI; Kim JW; Chu HH; Kim JH
Eur Radiol; 2020 Oct; 30(10):5650-5662. PubMed ID: 32409860
[TBL] [Abstract][Full Text] [Related]
6. p53 gene therapy-based transarterial chemoembolization for unresectable hepatocellular carcinoma: A prospective cohort study.
Shen A; Liu S; Yu W; Deng H; Li Q
J Gastroenterol Hepatol; 2015 Nov; 30(11):1651-6. PubMed ID: 25968838
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
8. Clinical therapeutic effect and biological monitoring of p53 gene in advanced hepatocellular carcinoma.
Chen S; Chen J; Xi W; Xu W; Yin G
Am J Clin Oncol; 2014 Feb; 37(1):24-9. PubMed ID: 24457472
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
Wang C; Liao Y; Qiu J; Yuan Y; Zhang Y; Li K; Zou R; Wang Y; Zuo D; He W; Zheng Y; Li B; Yuan Y
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human adenovirus p53 combined with transcatheter arterial chemoembolization for liver cancer: A meta-analysis.
Guo Y; Chen Y; Zhang Y; Xu M; Guo W; Zhang J; Ma G; Liu C; Yang J; Wu X
PLoS One; 2023; 18(12):e0295323. PubMed ID: 38127912
[TBL] [Abstract][Full Text] [Related]
11. Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma.
Kamada K; Kitamoto M; Aikata H; Kawakami Y; Kono H; Imamura M; Nakanishi T; Chayama K
Am J Surg; 2002 Sep; 184(3):284-90. PubMed ID: 12354601
[TBL] [Abstract][Full Text] [Related]
12. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
Lee HS; Kim JS; Choi IJ; Chung JW; Park JH; Kim CY
Cancer; 1997 Jun; 79(11):2087-94. PubMed ID: 9179054
[TBL] [Abstract][Full Text] [Related]
13. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
14. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma.
Yuan P; Zhang Z; Kuai J
J BUON; 2019; 24(1):163-170. PubMed ID: 30941966
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.
Ando Y; Kawaoka T; Amioka K; Naruto K; Ogawa Y; Yoshikawa Y; Kikukawa C; Kosaka Y; Uchikawa S; Morio K; Fujino H; Nakahara T; Murakami E; Yamauchi M; Tsuge M; Hiramatsu A; Fukuhara T; Mori N; Takaki S; Tsuji K; Nonaka M; Hyogo H; Aisaka Y; Masaki K; Honda Y; Moriya T; Naeshiro N; Takahashi S; Imamura M; Chayama K; Aikata H
Oncology; 2021; 99(8):507-517. PubMed ID: 33946070
[TBL] [Abstract][Full Text] [Related]
16. CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.
Xiang H; Long L; Yao Y; Fang Z; Zhang Z; Zhang Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819830751. PubMed ID: 30862264
[TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
He CB; Lao XM; Lin XJ
Chin J Cancer; 2017 Jul; 36(1):59. PubMed ID: 28728568
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
[TBL] [Abstract][Full Text] [Related]
19. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma.
Yin X; Zhang L; Wang YH; Zhang BH; Gan YH; Ge NL; Chen Y; Li LX; Ren ZG
BMC Cancer; 2014 Nov; 14():849. PubMed ID: 25409554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
